A clinical trial to study the effects of two drugs, Shigru kwatha and Livogrit in patients with Non Alcoholic Fatty Liver Disease

A Comparative Clinical Study of Shigru Kwatha and Livogrit in Yakritvikara (Non Alcholic Fatty Liver Disease) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058382

Enrollment

Registered

2023-10-06

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K759- Inflammatory liver disease, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient between the age group of 18 to 65 years will be selected. 2. Patient irrespective of gender, religion, occupation and chronicity will be selected for the study. 3. Both fresh and treated cases would be taken for the study. 4. Patient with Grade 1 and Grade 2 fatty liver only will be selected for the study. 5. Individual with controlled Diabetes Mellitus having Grade 1 and Grade 2 fatty liver will be selected for the study.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women will be excluded. 2. Patient who have had Hepatitis B,C or other hepatic viral infection , autoimmune hepatitis and drug induced hepatitis or alcoholic hepatitis will be excluded. 3. Patient with severe complication of the cardiovascular, renal or hematopoietic systems and mental disease will be excluded. 4. Patient will be excluded having decompensated liver disease. 5. Patient with prolonged or a history of ascites , developed Hepatocellular carcinoma Hepatic Encephalopathy , Variceal bleeding will be excluded. 6. Patient with a history of using IFN or antiviral agents or Corticosteroids or Immunosuppresive drugs will also be excluded.

Design outcomes

Primary

Measure	Time frame
Subjective criteria 1. Anorexia 2. Fatigue 3. Abdominal pain 4. Malaise 5. Indigestion(avipaka) 6. Polydipsia (pipasa) 7. Constipation 8. Vomiting (chhardi) 9. Fever (mridu jwara) 10. Flatulence (aanaha) 11. TastelessnessTimepoint: 0th day 30th day 60th day	—

Secondary

Measure	Time frame
Objective Criteria 1. Ultrasonography whole abdomen Timepoint: 0th day 60th day	—

Countries

India

Contacts

Public ContactDr C B Dhanraj

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar Uttarakhand

drcbdhanraj@gmail.com917396174582

Outcome results